BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 28598005)

  • 1. Higher concentrations of dithranol appear to induce hair growth even in severe alopecia areata.
    Ngwanya MR; Gray NA; Gumedze F; Ndyenga A; Khumalo NP
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28598005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pediatric alopecia areata with anthralin: A retrospective study of 37 patients.
    Wu SZ; Wang S; Ratnaparkhi R; Bergfeld WF
    Pediatr Dermatol; 2018 Nov; 35(6):817-820. PubMed ID: 30338548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
    Nasimi M; Ghandi N; Abedini R; Mirshamsi A; Shakoei S; Seirafi H
    Arch Dermatol Res; 2019 Oct; 311(8):607-613. PubMed ID: 31165933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin.
    Ibrahim SA; Esawy AM; Abdelshafy AS
    Dermatol Ther; 2019 Sep; 32(5):e13010. PubMed ID: 31237076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recalcitrant alopecia areata responsive to leflunomide and anthralin-Potentially undiscovered JAK/STAT inhibitors?
    Sardana K; Gupta A; Gautam RK
    Pediatr Dermatol; 2018 Nov; 35(6):856-858. PubMed ID: 30318623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
    Durdu M; Özcan D; Baba M; Seçkin D
    J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of azelaic acid and anthralin for the therapy of patchy alopecia areata: a pilot study.
    Sasmaz S; Arican O
    Am J Clin Dermatol; 2005; 6(6):403-6. PubMed ID: 16343028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Retrospective Review of Anthralin in Petrolatum in the Treatment of Alopecia Areata in the Pediatric Population.
    Zafrir Y; Tantuco K; Tangtatco AJA; Ho N
    J Cutan Med Surg; 2023; 27(5):449-453. PubMed ID: 37559401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of topical dithranol (Dithrocream
    Daunton A; Harries M
    Br J Dermatol; 2019 May; 180(5):1246-1247. PubMed ID: 30536990
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of anthralin in the treatment of alopecia areata.
    Fiedler-Weiss VC; Buys CM
    Arch Dermatol; 1987 Nov; 123(11):1491-3. PubMed ID: 3314718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin.
    Fiedler VC; Wendrow A; Szpunar GJ; Metzler C; DeVillez RL
    Arch Dermatol; 1990 Jun; 126(6):756-9. PubMed ID: 2140670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin.
    Tang L; Cao L; Sundberg JP; Lui H; Shapiro J
    Exp Dermatol; 2004 Jan; 13(1):5-10. PubMed ID: 15009110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral Half-Head Comparison of 1% Anthralin Ointment in Children with Alopecia Areata.
    Özdemir M; Balevi A
    Pediatr Dermatol; 2017 Mar; 34(2):128-132. PubMed ID: 28044367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata.
    Ghandi N; Daneshmand R; Hatami P; Abedini R; Nasimi M; Aryanian Z; Vance TM
    Int Immunopharmacol; 2021 Oct; 99():107971. PubMed ID: 34298402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral treatment for alopecia areata.
    Torchia D; Schachner LA
    Pediatr Dermatol; 2010; 27(4):415-6. PubMed ID: 20653874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alopecia areata.
    Perera E; Yip L; Sinclair R
    Curr Probl Dermatol; 2015; 47():67-75. PubMed ID: 26370645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood Alopecia Areata: An Overview of Treatment and Recent Patents.
    Hon KL; Luk DCK; Leung AKC; Ng C; Loo SKF
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(2):117-132. PubMed ID: 32723274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of topical calcipotriol in management of alopecia areata: A pilot study.
    Narang T; Daroach M; Kumaran MS
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of IL-1β and antimicrobial peptides as a potential mechanism for topical dithranol.
    Benezeder T; Gehad A; Patra V; Clark R; Wolf P
    Exp Dermatol; 2021 Jun; 30(6):841-846. PubMed ID: 33629779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical Calcipotriol Therapy for Mild-to-Moderate Alopecia Areata: A Retrospective Study.
    Çerman AA; Solak SS; Altunay İ; Küçükünal NA
    J Drugs Dermatol; 2015 Jun; 14(6):616-20. PubMed ID: 26091388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.